NYX Notes


6/7/2007 – Sandler report


Q4 2007 EPS Report and c-call (2/5/08)


Lehman Report 2/6/08


DBAB report 2/5/08


CSFB Report 12/10/2008

-          Overall activity levels have remained healthy

o        YTD US cash equities volume up 45%, European cash equities up 24% and EU derivatives up 10%

-          CSFB factoring 13-15% Y?Y declines industrywide US equities in 2009

-          Management believes historical growth rates of 10-15% are still in place long-term

-          Technology improvements helping to rebuild market share – more room for improvement

-          Integration of acquisitions ahead of schedule – expects $100 mil of expense synergies by early to mid 2009

-          Upcoming launch of cleared CDS contracts could provide growth

-          Strong Dollar has been a headwind as 40% of gross revenue and 70% of operating income is from European Operations

-          Uses of capital likely to approach $1 bil (dividend , data centers, large payment to LCH)

o        But EBITDA will generate $1.4 bil

o        Dividend yield now about 5%

-          $1 bil cash and equivalents and $3.2 bil debt which matures in 5-7 years

-          Long-term likely to use cash for share repurchases, but current environment requires more conservative approach.

 

EPS Release 2009-02-09

-          Pro-forma net income $137 mil (0.52 per share) versus 0.62 in Q4 2007

o        Excludes 4.59 bil non-cash charge for impairment of goodwill – no impact on debt covenants, cash-flow or operations

-          FY EPS $2.87 per share – up 9% versus 2007

-          Gross revenues up 21% in Q4 but net revenues not as strong due to rebates paid to liquidity providers

o        Volumes higher across most markets

-          Refraining from stock purchases but maintaining $0.30 quarterly div.

o        Balance between capital management and shareholder value

-          Focusing capital on growth initiatives while pruning back operating expenses on existing divisions

-          Plans to roll out new pricing model March 1

 

RAJA note 2/10/09

-          EPS of $0.52 shy of estimate, considerably down from Q3 2008

-          Third straight quarter of declining earnings

-          Drivers: - Decision to pursue market share at expense of pricing

o        Strong dollar also pressured EPS

-          Not optimistic with near-term 2009 outlook

o        Lower trading volumes y/y

o        Expenses related to growth initiatives will pressure margins

o        Decision to suspend share repurchase

-          LiffeClear (initiative to bring futures clearing in-house) may be lone hope for upside surprise

 

Barclays 2/10/09

-          Updated cost structure confusing to investors (investment in growth measures misconstrued as less cost reduction)

o        Hoping for more details during investor day – Wednesday

 

CSFB Report 2/10/09

-          Weaker than expected volumes and lower revenue capture trends

-          Could take few more quarters to provide clarity to drive stock price higher

-          Shares should find suppot near current valuations

-          Better than expected share gains to be offset by pricing compression

-          Management continues to target $370 m in synergies (250m from Euronext, $120 from AMEX)


Raymond James Note 4/23/09

-          Rumors of Deutsche Borse and NYSE Euronext merger

o        Companies acknowledged discussions back in December

-          Deutsche Borse may have more ability now that 2 activist investors who had previously blocked a deal are gone

-          Likely that deutsche borse would be buyer (larger market cap) and deal likelty to be equity based

-          Raymond James believes would be an integration nightmare

-          Deal would cover 50% of US option trading – dominate Europe Futures market and continental Europe Equity trading

-          ICE could be another attractive acquisition